Beranda › Tumor Neuroendokrin › Missouri › St. Louis
Uji klinis Tumor Neuroendokrin di St. Louis, MO
7 studi untuk Tumor Neuroendokrin mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Menerima pesertaFase 2/3
- Siteman Cancer Center, St Louis
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Menerima pesertaFase 1
- Research Facility, St Louis
- Research Facility, St Louis
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Menerima pesertaFase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Menerima pesertaFase 1/2
- Washington University, St Louis
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Menerima pesertaFase 2
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, St Louis
Uji klinis Tumor Neuroendokrin di kota lain
- Philadelphia, PA11 studi
- Washington, DC11 studi
- Rochester, MN9 studi
- Houston, TX8 studi
- Chicago, IL7 studi
- Columbus, OH7 studi
- Detroit, MI7 studi
- Salt Lake City, UT7 studi
- Cleveland, OH7 studi
- Dallas, TX6 studi
- Charlottesville, VA6 studi
- Miami, FL6 studi
Studi lain di St. Louis
- Kanker Paru Non-Sel Kecil73 studi
- Kanker Payudara64 studi
- Kanker Metastatik54 studi
- Kanker Kolorektal50 studi
- Kanker (semua jenis)46 studi
- Kanker Prostat46 studi
- Kanker Paru39 studi
- Kanker Ovarium38 studi
- Kanker Pankreas33 studi
- Kanker Endometrium29 studi
- Karsinoma Sel Skuamosa Kepala dan Leher28 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.